News

Cipla’s dolutegravir/lamivudine/tenofovir tablet prequalified

WHO Prequalification Team - Medicines (PQTm) added the below new products to its prequalified list:

  • HA702 - Dolutegravir (as sodium)/Lamivudine/Tenofovir disoproxil fumarate - 50mg/300mg/300mg - Tablet - Cipla Limited - INDIA

     
Related Links